CRNX vs. CCL

Last updated Jun 25, 2026

CRNX (Crinetics Pharmaceuticals, Inc.) and CCL (Carnival Corporation & Plc) are both stocks. CRNX operates in Biotechnology (Healthcare), while CCL operates in Travel Services (Consumer Cyclical). Over the past 5 years, CRNX returned 13.02%/yr vs 0.76%/yr for CCL. At a 0.24 correlation, their price movements are largely independent.

Performance

CRNX vs. CCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Crinetics Pharmaceuticals, Inc. (CRNX) and Carnival Corporation & Plc (CCL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRNX achieves a -22.28% return, which is significantly lower than CCL's -4.32% return.

CRNX

• 1D: 0.75%
• 1M: -1.68%
• YTD: -22.28%
• 6M: -25.72%
• 1Y: 16.94%
• 3Y*: 25.03%
• 5Y*: 13.02%
• 10Y*: —

CCL

• 1D: 0.66%
• 1M: 11.28%
• YTD: -4.32%
• 6M: -6.49%
• 1Y: 13.70%
• 3Y*: 22.75%
• 5Y*: 0.76%
• 10Y*: -3.18%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRNX vs. CCL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
CRNX Crinetics Pharmaceuticals, Inc.	-22.28%	-8.96%	43.70%	94.43%	-35.59%	101.35%	-43.76%	-16.34%	55.79%
CCL Carnival Corporation & Plc	-4.32%	22.55%	34.41%	130.02%	-59.94%	-7.11%	-56.89%	7.37%	-14.46%

Correlation

The correlation between CRNX and CCL is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.29
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.31
Correlation (All Time) Calculated using the full available price history since Jul 18, 2018	0.24

Fundamentals

Market Cap CRNX : $3.77B CCL : $40.24B
EPS CRNX : -$5.14 CCL : $2.21
PS Ratio CRNX : 221.16 CCL : 1.50
PB Ratio CRNX : 2.94 CCL : 3.09
Total Revenue (TTM) CRNX : $15.79M CCL : $26.98B
Gross Profit (TTM) CRNX : $16.05M CCL : $10.13B
EBITDA (TTM) CRNX : -$531.75M CCL : $7.23B

Return for Risk

CRNX vs. CCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRNX

CRNX Risk / Return Rank: 53
CRNX Sharpe Ratio Rank: 54
CRNX Sortino Ratio Rank: 55
CRNX Omega Ratio Rank: 52
CRNX Calmar Ratio Rank: 53
CRNX Martin Ratio Rank: 52

CCL

CCL Risk / Return Rank: 53
CCL Sharpe Ratio Rank: 54
CCL Sortino Ratio Rank: 52
CCL Omega Ratio Rank: 50
CCL Calmar Ratio Rank: 54
CCL Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRNX vs. CCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Crinetics Pharmaceuticals, Inc. (CRNX) and Carnival Corporation & Plc (CCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRNX	CCL	Difference
Sharpe ratio: Return per unit of total volatility	0.30	0.29	+0.01
Sortino ratio: Return per unit of downside risk	0.92	0.79	+0.12
Omega ratio: Gain probability vs. loss probability	1.11	1.09	+0.02
Calmar ratio: Return relative to maximum drawdown	0.40	0.47	-0.07
Martin ratio: Return relative to average drawdown	0.81	0.94	-0.13

CRNX vs. CCL - Sharpe Ratio Comparison

The current CRNX Sharpe Ratio is 0.30, which is comparable to the CCL Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of CRNX and CCL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CRNX vs. CCL - Drawdown Comparison

The maximum CRNX drawdown since its inception was -68.70%, smaller than the maximum CCL drawdown of -90.37%. Use the drawdown chart below to compare losses from any high point for CRNX and CCL.

Drawdown Indicators

	CRNX	CCL	Difference
Max Drawdown Largest peak-to-trough decline	-68.70%	-90.37%	+21.67%
Max Drawdown (1Y) Largest decline over 1 year	-42.21%	-29.30%	-12.91%
Max Drawdown (3Y) Largest decline over 3 years	-57.88%	-42.85%	-15.03%
Max Drawdown (5Y) Largest decline over 5 years	-57.88%	-77.32%	+19.44%
Max Drawdown (10Y) Largest decline over 10 years	—	-90.37%	—
Current Drawdown Current decline from peak	-40.39%	-55.87%	+15.48%
Average Drawdown Average peak-to-trough decline	-37.34%	-28.60%	-8.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.94%	14.65%	+6.29%

Volatility

CRNX vs. CCL - Volatility Comparison

The current volatility for Crinetics Pharmaceuticals, Inc. (CRNX) is 12.42%, while Carnival Corporation & Plc (CCL) has a volatility of 15.68%. This indicates that CRNX experiences smaller price fluctuations and is considered to be less risky than CCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRNX	CCL	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.42%	15.68%	-3.26%
Volatility (6M) Calculated over the trailing 6-month period	36.41%	38.21%	-1.80%
Volatility (1Y) Calculated over the trailing 1-year period	57.29%	47.68%	+9.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	63.86%	55.67%	+8.19%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	65.67%	57.67%	+8.00%

Dividends

CRNX vs. CCL - Dividend Comparison

CRNX has not paid dividends to shareholders, while CCL's dividend yield for the trailing twelve months is around 1.04%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CCL Carnival Corporation & Plc	1.04%	0.00%	0.00%	0.00%	0.00%	0.00%	2.31%	3.93%	3.96%	2.41%	2.59%	2.02%
CRNX Crinetics Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both CRNX and CCL in my portfolio?

CRNX and CCL have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRNX or CCL?

CCL has higher volatility (15.68%) compared to CRNX (12.42%). In terms of maximum drawdown, CRNX dropped -68.70% vs CCL's -90.37%.

Which has better risk-adjusted returns?

CRNX currently has the higher Sharpe Ratio (0.30 vs 0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.